about
Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen ConsumptionHabitual Physical Activity in Adults With Congenital Heart Disease Compared With Age- and Sex-Matched Controls.Height, weight and body mass index in adults with congenital heart disease.Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark.Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia.Mitroflow pericardial bioprosthesis in the aortic position. Low incidence of structural valve deterioration in elderly patients during an 11-year follow-up.Response letter to: "hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts?Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology.Development and evaluation of a computer-based educational program for adults with congenitally malformed hearts.Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.Atrial myocardial pathoelectrophysiology in adults with a secundum atrial septal defect is unaffected by closure of the defect. A study using high resolution signal-averaged orthogonal P-wave technique.The level of physical exercise is associated with self-reported health status (EQ-5D) in adults with congenital heart disease.Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.Management of grown up congenital heart disease.Decline in self-reported health (EQ-5D) over time after surgical reconstruction of the right ventricular outflow tract: a longitudinal cohort study of 103 patients.Adults with complex congenital heart disease have impaired skeletal muscle function and reduced confidence in performing exercise training.[Congenital abnormalities require life-long follow up][Marfan syndrome and pregnancy][The number of adults with congenital heart defects is increasing. Who will take care of them?]Does the risk of infective endarteritis justify routine patent ductus arteriosus closure?Infective Endocarditis in Adults with Congenital Heart DiseaseAtrial septal defect in adults. Thirty-eight-year follow-up of a surgically and a conservatively managed group[Adults with congenital heart defects--a growing patient group]Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder deviceFunctional evaluation of extracardiac ventriculopulmonary conduits and of the right ventricle with magnetic resonance imaging and velocity mappingClosure of atrial septal defect: is the debate over?[GUCH--grown-up congenital heart disease--adults with congenital heart defects. The number of adults with congenital heart defects is increasing with the developments in pediatric cardiology]Closure of atrial septal defect in the adult. Cardiac remodeling is an early eventThe spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart diseaseAdherence to guidelines in the clinical care for adults with congenital heart disease: the Euro Heart Survey on adult congenital heart diseaseEarly valve failure in a first-in-man implant with an Edwards SAPIEN XT valve using the split sheath NovaFlex system in the treatment of a pulmonary conduit stenosisHemodynamic causes of exercise intolerance in Fontan patients
P50
Q38420150-1763DC36-8F10-4F11-B634-8AAFA4F460D2Q40970590-1B7E97A6-9124-4717-AC77-7927000622F3Q41119706-372BAB73-6CF0-4A77-8788-38CE46A474EFQ41576664-E0CB07E1-1A8A-4405-A561-F12927F5DB0CQ41689979-50BDE897-B164-423C-9B2B-169F092EBC53Q42661122-C20F6F67-111D-4EA4-84FF-7D7C907EC6EAQ43728744-024221DE-07C1-4548-9525-F3BDD4A6E301Q44212070-1FCC786D-EA03-4C21-915B-9C5EE3C0D682Q45096607-ED11DCCC-7419-44BE-8FA6-1B43B76E1D37Q45784122-BBAC4989-3FBE-4B4E-B0D6-B508C7288F5CQ46322507-934686E6-3604-4F93-AE19-6C6FC5BFBC98Q46469516-8936B9C4-E4F7-454A-832D-819274709FF6Q46979672-3D47C9BE-A547-4987-B4E4-9C08B3BAE2B0Q47943449-AF82D732-696F-4350-9621-ABC1063D0844Q48155370-38559E78-26AD-4D52-A742-027FA42257C8Q48378197-87E073A5-5369-4913-9211-E37410E41FD5Q48970369-3B9BBB8C-0390-47E6-B81A-EA260A484A98Q51119902-FBF4C9DE-9955-41AD-8DAD-0790B5258B97Q51709783-6E98AD80-1AFD-4B2E-A2D1-5C3359F7C0E4Q58861789-358708EF-FE87-4A41-9883-0A2541077179Q70552598-35690F3D-4FDA-492B-9A5D-7B22437BD8F4Q72727227-E3A15D8A-C3BE-4BE4-8796-8F7CCE767C30Q73168149-88C3FF10-4E50-416F-8BB7-FAFBF674B3EEQ73681654-391F6964-BBAE-4141-8BB6-23582980E711Q73803819-D9DCFA5E-B968-4356-8058-D06AD18CC6E0Q74274772-0F627277-7903-4218-9D1C-3E363110D137Q74306554-56E9E2E4-DFF0-48DB-9356-5C2F350AABC9Q77220514-499DD5D6-AB56-4720-B7A2-894A797D2CEBQ79106996-BCF2AD72-C3FA-4E38-BA51-DD3315785977Q81226184-283AD96A-217F-4958-BAC8-B453D654D139Q81896859-35883D2A-0463-40FE-A206-42F126C4075AQ81923981-F231F999-7D8C-4251-B9B7-9C73986C0A0FQ82214095-ACEE571F-DCB3-450E-B5EC-021A42B37C0DQ86606733-AE1E33ED-62C7-468D-9D9C-FF3CE8A17B9DQ95434226-73A8726B-F54C-4B4F-8C02-ED376E50FCF9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ulf Thilén
@ast
Ulf Thilén
@en
Ulf Thilén
@es
Ulf Thilén
@nl
Ulf Thilén
@sl
type
label
Ulf Thilén
@ast
Ulf Thilén
@en
Ulf Thilén
@es
Ulf Thilén
@nl
Ulf Thilén
@sl
prefLabel
Ulf Thilén
@ast
Ulf Thilén
@en
Ulf Thilén
@es
Ulf Thilén
@nl
Ulf Thilén
@sl
P106
P21
P31
P496
0000-0001-8651-4878
P569
2000-01-01T00:00:00Z